To date, large, well-designed studies addressing the role of 68GA-PSMA-HBED-CC or 18F-DCFPyl PET/CT imaging targeting PSMA expression on tumors other than prostate carcinoma are lacking. The gene discussed is FOLH1; the disease is prostate carcinoma.